Clinical and molecular characteristics of responders versus non-responders to immune checkpoint inhibitors (ICI) in NSCLC.

被引:1
|
作者
Shah, Arpeet
Padda, Sukhmani K.
Neal, Joel W.
机构
[1] Stanford Canc Ctr, Stanford, CA USA
[2] Stanford Canc Inst, Stanford, CA USA
关键词
D O I
10.1200/JCO.2019.37.8_suppl.114
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
114
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Comparison of Clinical Characteristics between Responders and Non-Responders to Hamstring Stretching in Individuals with Chronic Low Back Pain
    Dobija, Lech
    Pereira, Bruno
    Dupeyron, Arnaud
    Coudeyre, Emmanuel
    DIAGNOSTICS, 2024, 14 (19)
  • [42] Identifying responders versus non-responders: Incorporation of controls is required for sound statistical inference
    Padilla, Jaume
    Leary, Emily
    Limberg, Jacqueline K.
    EXPERIMENTAL PHYSIOLOGY, 2021, 106 (02) : 375 - 376
  • [43] Different network functional connectivity characteristics of responders and non-responders to attention training in MS
    Prouskas, S. E.
    Steenwijk, M. D.
    Gehring, K.
    Huiskamp, M.
    de Jong, B.
    Geurts, J. J. G.
    Sitskoorn, M. M.
    Schoonheim, M. M.
    Hulst, H. E.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (08) : NP10 - NP11
  • [44] NEUROCHEMICAL CHARACTERISTICS OF RATS DISTINGUISHED AS BENZODIAZEPINE RESPONDERS AND NON-RESPONDERS IN A NEW CONFLICT TEST
    PATEL, JB
    STENGEL, J
    MALICK, JB
    ENNA, SJ
    LIFE SCIENCES, 1984, 34 (26) : 2647 - 2653
  • [45] Different network functional connectivity characteristics of responders and non-responders to attention training in MS
    Prouskas, S. E.
    Steenwijk, M. D.
    Gehring, K.
    Huiskamp, M.
    de Jong, B. A.
    Geurts, J. J. G.
    Sitskoorn, M. M.
    Schoonheim, M. M.
    Hulst, H. E.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 353 - 354
  • [46] Clinical differences between responders and non-responders to interferon beta treatment in multiple sclerosis
    Karabudak, R.
    Kurne, A.
    Aydin, O. F.
    Sayat, G.
    Acar, P.
    MULTIPLE SCLEROSIS, 2007, 13 : S51 - S52
  • [47] INDOMETHACIN IN RHEUMATOID-ARTHRITIS - CLINICAL AND BIOCHEMICAL EFFECTS AND PHARMACOKINETICS IN RESPONDERS AND NON-RESPONDERS
    ORME, MLE
    BABER, N
    HALLIDAY, LDC
    KEENAN, J
    SIBEON, R
    VANDENHEUVEL, W
    LITTLER, T
    ANNALS OF THE RHEUMATIC DISEASES, 1978, 37 (06) : 575 - 576
  • [48] CLINICAL AND EEG EFFECTS OF HYDROXYMAPROTILINE IN DEPRESSIVE PATIENTS WITH SPECIAL REFERENCE TO RESPONDERS AND NON-RESPONDERS
    BENTE, D
    FAHNDRICH, E
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1980, 30-2 (08): : 1227 - 1227
  • [49] Characteristics of non-responders to diabetes service use questionnaires
    Goyder, EC
    Botha, JL
    PUBLIC HEALTH, 2001, 115 (01) : 78 - 79
  • [50] Active lymphocytic myocarditis: virologic and immunologic profile of responders versus non-responders to immunosuppressive therapy
    Chimenti, C
    Pieroni, M
    Calabrese, F
    Verardo, R
    Thiene, G
    Maseri, A
    Frustaci, A
    EUROPEAN HEART JOURNAL, 2002, 23 : 149 - 149